Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Update

Lonza Group Ag (OTCMKTS:LZAGY) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totaling 27,701 shares, an increase of 393.0% from the December 31st total of 5,619 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 75,219 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily volume of 75,219 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.0% of the shares of the company are sold short.

Lonza Group Price Performance

Lonza Group stock traded down $0.55 during midday trading on Thursday, reaching $69.95. 105,405 shares of the company’s stock were exchanged, compared to its average volume of 66,586. The stock’s 50-day simple moving average is $68.06 and its 200 day simple moving average is $68.79. The company has a current ratio of 1.46, a quick ratio of 0.87 and a debt-to-equity ratio of 0.48. Lonza Group has a 52 week low of $55.57 and a 52 week high of $73.85.

About Lonza Group

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.